Shareholders who lost money in American Depositary Receipts of PomDoctor, Ltd. (NASDAQ: POM) Should Contact Wolf Haldenstein Immediately
Idag, 00:13
Shareholders who lost money in American Depositary Receipts of PomDoctor, Ltd. (NASDAQ: POM) Should Contact Wolf Haldenstein Immediately
PR Newswire
NEW YORK, Feb. 18, 2026
Lead Plaintiff Deadline is April 6, 2026
NEW YORK , Feb. 18, 2026 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed against PomDoctor, Ltd. (NASDAQ: POM) ("PomDoctor" or the "Company") inclusive on behalf of all persons and entities that purchased or otherwise acquired PomDoctor American Depositary Receipts ("ADR's") between October 9, 2025 and December 11, 2025, both dates inclusive (the "Class Period"). Investors have until April 6, 2026, to seek appointments as lead plaintiff.
PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:
- that PomDoctor was the subject of a fraudulent stock promotion scheme
involving social media-based misinformation and impersonated financial
professionals; - that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign;
- that PomDoctor's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price, and;
- As a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading at all relevant times.
Investors seeking appointment as Lead Plaintiff may file a motion with the court no later than April 6, 2026 .
Why Wolf Haldenstein Adler Freeman & Herz LLP?:
This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors.
We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman & Herz LLP.
Contact:
- Phone: (800) 575-0735 or (212) 545-4774
- Email: classmember@whafh.com
- Contact Person:Gregory Stone, Director of Case and Financial Analysis
Firm Website: Wolf Haldenstein Adler Freeman & Herz LLP
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
SOURCE Wolf Haldenstein Adler Freeman & Herz LLP
Ämnen i artikeln
Shareholders who lost money in American Depositary Receipts of PomDoctor, Ltd. (NASDAQ: POM) Should Contact Wolf Haldenstein Immediately
Idag, 00:13
Shareholders who lost money in American Depositary Receipts of PomDoctor, Ltd. (NASDAQ: POM) Should Contact Wolf Haldenstein Immediately
PR Newswire
NEW YORK, Feb. 18, 2026
Lead Plaintiff Deadline is April 6, 2026
NEW YORK , Feb. 18, 2026 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed against PomDoctor, Ltd. (NASDAQ: POM) ("PomDoctor" or the "Company") inclusive on behalf of all persons and entities that purchased or otherwise acquired PomDoctor American Depositary Receipts ("ADR's") between October 9, 2025 and December 11, 2025, both dates inclusive (the "Class Period"). Investors have until April 6, 2026, to seek appointments as lead plaintiff.
PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:
- that PomDoctor was the subject of a fraudulent stock promotion scheme
involving social media-based misinformation and impersonated financial
professionals; - that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign;
- that PomDoctor's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price, and;
- As a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading at all relevant times.
Investors seeking appointment as Lead Plaintiff may file a motion with the court no later than April 6, 2026 .
Why Wolf Haldenstein Adler Freeman & Herz LLP?:
This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors.
We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman & Herz LLP.
Contact:
- Phone: (800) 575-0735 or (212) 545-4774
- Email: classmember@whafh.com
- Contact Person:Gregory Stone, Director of Case and Financial Analysis
Firm Website: Wolf Haldenstein Adler Freeman & Herz LLP
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
SOURCE Wolf Haldenstein Adler Freeman & Herz LLP
Ämnen i artikeln
Rapporter
Analys
Rapportrasen
E-handeln
Rapporter
Analys
Rapportrasen
E-handeln
Marknadsöversikt
1 DAG %
Senast
1 mån
-992x558.jpg&w=3840&q=75)